Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmedeo Afp Regulatory News (AA4)

  • This share is currently suspended. It was suspended at a price of 72.40
  • There is currently no data for AA4

Update Statement On Voting Results

22 Jun 2021 14:00

RNS Number : 7387C
Amedeo Air Four Plus Limited
22 June 2021
 

 

 

 

 

AMEDEO AIR FOUR PLUS LIMITED (the "Company")

Legal Entity Identifier: 21380056PDNOTWERG107

 

Update Statement On Voting Results - Annual General Meeting of 7 December 2020

 

At the annual general meeting of the Company held on 7 December 2020 (the "AGM") 20 per cent. or more of votes cast were cast against the resolutions listed below:

 

Resolution

For

Against

Vote Withheld

4

To re-elect Mr David Gelber as a director of the Company

253,757,832

82,965,053

20,479,188

5

To re-elect Mr John Le Prevost as a director of the Company

227,917,661

108,805,224

20,479,188

The Company has consulted with the shareholders who voted against the above resolutions in order to understand and address their concerns. The responses received indicate that voting against the resolutions reflected:

· a lack of information regarding the Board's decision making process, specifically in regard to dividend payments and returns of capital;

· a general lack of engagement with the Company's shareholders;

· the Board's management of its relationship with Nimrod Capital LLP; and

· concerns over the Company's governance, specifically in relation to the independence of the directors and members of the Audit Committee.

During the period since the AGM, the Board has been focused on improving communications with shareholders and improving governance within the Company. Actions taken to date include:

· the termination of the appointment of Nimrod Capital LLP as the Company's sole corporate and shareholder advisor with effect from 31 January 2021 and settlement of outstanding matters between them and the Company;

· the appointment of Liberum as the Company's sole corporate broker with effect from 15 March 2021;

· the introduction of more frequent investor webinars; and

· a focus on increasing the level of disclosure made by the Company.

The Board would like to thank all shareholders that took part in the engagement process and values the feedback and insight it has gained. A final update on this matter will be included in the Company's annual financial report for year end 31 March 2021.

For further information, please contact:

JTC Fund Solutions (Guernsey) Limited

+44 (0) 1481 702 400

 Liberum Capital Limited

Chris Clarke / Darren Vickers / Owen Matthews

+44 (0) 20 3100 2000

About the Company

The Company is a Guernsey-domiciled company, with shares admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market (LSE: AA4).

The Company's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMLLLFLFQLEBBD
Date   Source Headline
14th May 20252:54 pmRNSHolding(s) in Company
2nd May 202511:41 amRNSHolding(s) in Company
1st May 20251:46 pmRNSFACTSHEET
2nd Apr 202510:42 amRNSDividend Declaration
18th Mar 20251:30 pmRNSHolding(s) in Company
5th Mar 202512:55 pmRNSAA4P Beta (MSN164) Redelivery Condition
12th Feb 20257:00 amRNSFactsheet
31st Jan 20257:00 amRNSCompletion of Compulsory Redemption of Shares
23rd Jan 20257:00 amRNSCompulsory Redemption of Shares
16th Jan 20252:24 pmRNSHolding(s) in Company
14th Jan 20254:18 pmRNSAA4P Alpha (MSN157) Redelivery Condition
9th Jan 20253:29 pmRNSDividend Declaration
19th Dec 20247:00 amRNSHalf-year Report
6th Dec 20241:32 pmRNSResult of AGM
15th Nov 20247:00 amRNSNotice of AGM
6th Nov 20247:00 amRNSFactsheet
3rd Oct 20247:00 amRNSDividend Declaration
9th Aug 20247:00 amRNSFactsheet
26th Jul 20247:00 amRNSAnnual Financial Report
2nd Jul 20247:00 amRNSDividend Declaration
13th Jun 20247:00 amRNSHolding(s) in Company
22nd May 20241:43 pmRNSHolding(s) in Company
8th May 20247:00 amRNSFactsheet
2nd May 202412:04 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirectorate Change
2nd Apr 202410:57 amRNSDividend Declaration
28th Mar 20249:21 amRNSDirectorate Change
13th Feb 20247:00 amRNSFactsheet
11th Jan 20241:56 pmRNSDividend Declaration
20th Dec 20237:00 amRNSHalf-year Report
8th Dec 20234:30 pmRNSResult of AGM
20th Nov 20237:00 amRNSNotice of AGM
16th Nov 20232:24 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSFACTSHEET
3rd Oct 20237:00 amRNSDividend Declaration
11th Aug 20237:00 amRNSFactsheet and Investor Call
31st Jul 20237:00 amRNSAnnual Financial Report
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:17 amRNSDividend Declaration
24th May 20236:03 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSFactsheet
4th Apr 20237:00 amRNSDividend Declaration
1st Mar 20237:00 amRNSCompletion Partial Compulsory Redemption & TVR
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
22nd Feb 20237:01 amRNSReturn of Capital and Increased Quarterly Dividend
22nd Feb 20237:00 amRNSFactsheet
19th Jan 20237:00 amRNSDirectorate Change
13th Jan 20234:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.